These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33093014)

  • 41. Peroxisome proliferator-activated receptors, coactivators, and downstream targets.
    Qi C; Zhu Y; Reddy JK
    Cell Biochem Biophys; 2000; 32 Spring():187-204. PubMed ID: 11330046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
    Ge CX; Yu R; Xu MX; Li PQ; Fan CY; Li JM; Kong LD
    Eur J Pharmacol; 2016 Jan; 770():154-64. PubMed ID: 26593707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption.
    Tardelli M; Bruschi FV; Claudel T; Fuchs CD; Auer N; Kunczer V; Stojakovic T; Scharnagl H; Habib A; Grabner GF; Zimmermann R; Lotersztajn S; Trauner M
    J Lipid Res; 2019 Jul; 60(7):1284-1292. PubMed ID: 31048404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 14-3-3β and γ differentially regulate peroxisome proliferator activated receptor γ2 transactivation and hepatic lipid metabolism.
    Park S; Yoo S; Kim J; An HT; Kang M; Ko J
    Biochim Biophys Acta; 2015 Oct; 1849(10):1237-47. PubMed ID: 26260846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.
    Hashimoto T; Cook WS; Qi C; Yeldandi AV; Reddy JK; Rao MS
    J Biol Chem; 2000 Sep; 275(37):28918-28. PubMed ID: 10844002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression.
    Yu S; Matsusue K; Kashireddy P; Cao WQ; Yeldandi V; Yeldandi AV; Rao MS; Gonzalez FJ; Reddy JK
    J Biol Chem; 2003 Jan; 278(1):498-505. PubMed ID: 12401792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
    Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
    Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.
    Wang XC; Zhan XR; Li XY; Yu JJ; Liu XM
    World J Gastroenterol; 2014 Dec; 20(47):17914-23. PubMed ID: 25548489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease.
    Li X; Wang Z; Klaunig JE
    Toxicology; 2018 Dec; 410():199-213. PubMed ID: 30120929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peroxisome-proliferator-activated receptors as physiological sensors of fatty acid metabolism: molecular regulation in peroxisomes.
    Latruffe N; Cherkaoui Malki M; Nicolas-Frances V; Jannin B; Clemencet MC; Hansmannel F; Passilly-Degrace P; Berlot JP
    Biochem Soc Trans; 2001 May; 29(Pt 2):305-9. PubMed ID: 11356172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.
    Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W
    Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.
    Montagner A; Polizzi A; Fouché E; Ducheix S; Lippi Y; Lasserre F; Barquissau V; Régnier M; Lukowicz C; Benhamed F; Iroz A; Bertrand-Michel J; Al Saati T; Cano P; Mselli-Lakhal L; Mithieux G; Rajas F; Lagarrigue S; Pineau T; Loiseau N; Postic C; Langin D; Wahli W; Guillou H
    Gut; 2016 Jul; 65(7):1202-14. PubMed ID: 26838599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.
    Sugden MC; Bulmer K; Gibbons GF; Knight BL; Holness MJ
    Biochem J; 2002 Jun; 364(Pt 2):361-8. PubMed ID: 12023878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
    Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
    World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver-specific deletion of IGF2 mRNA binding protein-2/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation.
    Regué L; Minichiello L; Avruch J; Dai N
    J Biol Chem; 2019 Aug; 294(31):11944-11951. PubMed ID: 31209109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Arid1a Loss Drives Nonalcoholic Steatohepatitis in Mice Through Epigenetic Dysregulation of Hepatic Lipogenesis and Fatty Acid Oxidation.
    Moore A; Wu L; Chuang JC; Sun X; Luo X; Gopal P; Li L; Celen C; Zimmer M; Zhu H
    Hepatology; 2019 May; 69(5):1931-1945. PubMed ID: 30584660
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wild ginseng cambial meristematic cells ameliorate hepatic steatosis and mitochondrial dysfunction in high-fat diet-fed mice.
    Lee SB; Cho HI; Jin YW; Lee EK; Ahn JY; Lee SM
    J Pharm Pharmacol; 2016 Jan; 68(1):119-27. PubMed ID: 26806698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis.
    Sozio MS; Liangpunsakul S; Crabb D
    Semin Liver Dis; 2010 Nov; 30(4):378-90. PubMed ID: 20960377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.